Beauty Health Co. Insider Ronald Menezes Files Form 4

TL;DR

**Insider Ronald Menezes just filed a Form 4 for Beauty Health Co., signaling a change in his holdings.**

AI Summary

Ronald Menezes, an insider at Beauty Health Co., filed a Form 4 on March 24, 2026, indicating a change in his beneficial ownership of the company's securities as of March 20, 2026. While the filing details aren't fully provided in the prompt, a Form 4 typically reports transactions like stock sales, purchases, or option exercises by company insiders. This matters to investors because insider activity can signal management's confidence (or lack thereof) in the company's future prospects, potentially influencing stock price.

Why It Matters

This filing signals a change in an insider's stake, which can be interpreted by the market as a vote of confidence or concern, potentially impacting investor sentiment and stock valuation.

Risk Assessment

Risk Level: medium — The risk is medium because without the transaction details, the impact on the stock is unknown; it could be positive or negative depending on whether shares were bought or sold.

Analyst Insight

An investor should await the full details of the Form 4 to understand if Ronald Menezes bought or sold shares, and then assess the potential implications for Beauty Health Co's stock price.

Key Players & Entities

• Menezes Ronald (person) — Reporting insider
• Beauty Health Co (company) — Issuer of securities
• 0001831441 (person) — CIK of Ronald Menezes
• 0001818093 (company) — CIK of Beauty Health Co

Forward-Looking Statements

• The market will react to the specific details of Ronald Menezes's transactions once they are fully disclosed. (Beauty Health Co) — medium confidence, target: 2026-03-25

FAQ

Filing Documents

• wk-form4_1774386239.html (4)
• wk-form4_1774386239.xml (4) — 4KB
• 0001628280-26-020848.txt ( ) — 5KB

From the Filing

SEC FORM 4 SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. 1. Name and Address of Reporting Person * Menezes Ronald (Last) (First) (Middle) C/O THE BEAUTY HEALTH COMPANY 3600 E. BURNETT STREET (Street) LONG BEACH CALIFORNIA 90815 (City) (State) (Zip) UNITED STATES (Country) 2. Issuer Name and Ticker or Trading Symbol Beauty Health Co [ SKIN ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Chief Revenue Officer 2a. Foreign Trading Symbol 3. Date of Earliest Transaction (Month/Day/Year) 03/20/2026 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person 4. If Amendment, Date of Original Filed (Month/Day/Year) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Class A Common Stock 03/20/2026 A (1) 746,681 A (1) 1,759,915 D Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Explanation of Responses: 1. Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock of The Beauty Health Company (the "Company"). The RSUs are subject to time-vesting conditions. The RSUs vest in one-third increments on each of the first three anniversaries of the grant date of March 20, 2026, in each case subject to continued service with the Company through the vesting date and certain acceleration rights. Remarks: /s/ Paul Bokota, Attorney-in-fact for Ronald Menezes 03/24/2026 ** Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. * Form 4: SEC 1474 (03-26)

View Full Filing

View this 4 filing on SEC EDGAR